Back to search

National and Kapodistrian University of Athens

Διερεύνηση της χρήσης της διπλής αντιαιμοπεταλειακής αγωγής σε ασθενείς με στεφανιαία νόσο που υποβήθησαν σε αγγειοπλαστική, ως προς την συμμόρφωση των ασθενών και την εμφάνιση επιπλοκών

Abstract

dc:description

Cardiovascular diseases are the first cause of death in western societies and are now the biggest problem for public health and also the leading cause of death in the European Union, with over 2 million deaths per year. Men prevail over the incidence of cardiovascular disease up to about 70 years of age.Different risk levels of ACS patients create difficulties in treating them evenly. Thus, therapeutic interventions in the individual patient should be guided by the so-called ischemic risk of this patient. A second risk that should be considered in these patients is the hemorrhagic risk due to the frequent use of intense antithrombotic therapy. Purpose: The aim of the study was to study the ischemic prognostic scores GRACE and CHA2DS2-VASc, as well as the HAS-BLED and CRUSADE hemorrhagic prognostic scores in patients underwent angioplasty to highlight which is best predicting the ischemic and hemorrhagic Risk.The compliance with the use of dual antiplatelet therapy and the occurrence of complications, was also studied.Results: The patients who participated in the study were a total of 667 with an average age of 61 ± 11 years and were followed-up for a period of 2 years. The GRACE score and its predicted incidence at 3 years, was compared to the CHA2DS2-VASc score, which predicts the annual probability of ischemic. This is the first time that the two scores are compared in a group of patients with coronary artery disease. In the limited study population (n = 667), the CHA2DS2-VASc score was able to show a marginally better prognosis of future ischemic events, with an area under the curve (AUC) of 0.624 vs 0.608 of the GRACE score. On the contrary, the predictive capacity of the haemorrhagic scores was not able to be shown in this sample of patients due to the limited number of the sample but also to the limited number of the occured bleedings (CRUCADE vs. HAS-BLED: AUC = 0.526 for both). Patient compliance for DAPT for at least one year was 79%, with the main cause of cessation being the financial crisis and bleeding. Regarding the correlation of the occurrence of the various complications with the educational level of the patients, there appeared to be a slight tendency for more hemorrhages in the patients who had higher education than in the secondary ones (10% vs. 5.2%, p = 0.102) . The first population group had a tendency for more frequent MACCE (12% vs. 6.9%, p = 0.128). Conclusions: In the specific population of this study, the CHA2DS2-VASc score was able to show a marginally higher predictive value in the emergence of future ischemic (MACCE) than the GRACE score (the predicted incidence in 3 years), in patients with angioplasty. In contrast, the hemorrhagic risk scores CRUSADE and HAS-BLED, failed to predict the observed bleeding due to a small number of these. Finally, the financial crisis played an important role in halting dual antiplatelet education before the year.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Trantalis, Georgios
  • Τρανταλής, Γεώργιος

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43292

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Trantalis, Georgios; Τρανταλής, Γεώργιος. Διερεύνηση της χρήσης της διπλής αντιαιμοπεταλειακής αγωγής σε ασθενείς με στεφανιαία νόσο που υποβήθησαν σε αγγειοπλαστική, ως προς την συμμόρφωση των ασθενών και την εμφάνιση επιπλοκών. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43292